| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transition metal ion binding | ADAMTS15 ZNF195 KMT2A CPD TNKS HDAC6 PPEF2 MSMO1 ADAMTS1 TET1 | 2.52e-05 | 1189 | 35 | 10 | GO:0046914 |
| GeneOntologyMolecularFunction | zinc ion binding | 1.22e-04 | 891 | 35 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.01e-04 | 200 | 35 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 4.49e-04 | 18 | 35 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | dynein complex binding | 1.10e-03 | 28 | 35 | 2 | GO:0070840 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 1.10e-03 | 28 | 35 | 2 | GO:0003950 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.20e-03 | 120 | 35 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 1.26e-03 | 30 | 35 | 2 | GO:1990404 | |
| GeneOntologyMolecularFunction | carboxy-lyase activity | 1.81e-03 | 36 | 35 | 2 | GO:0016831 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 2.37e-03 | 152 | 35 | 3 | GO:0016779 | |
| GeneOntologyMolecularFunction | tau protein binding | 2.94e-03 | 46 | 35 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | iron ion binding | 3.04e-03 | 166 | 35 | 3 | GO:0005506 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 4.18e-03 | 55 | 35 | 2 | GO:0051879 | |
| GeneOntologyMolecularFunction | pentosyltransferase activity | 4.33e-03 | 56 | 35 | 2 | GO:0016763 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 4.33e-03 | 56 | 35 | 2 | GO:0016830 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.41e-04 | 164 | 34 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.54e-04 | 85 | 34 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | Sin3-type complex | 5.81e-04 | 22 | 34 | 2 | GO:0070822 | |
| GeneOntologyCellularComponent | pericentriolar material | 9.45e-04 | 28 | 34 | 2 | GO:0000242 | |
| GeneOntologyCellularComponent | aggresome | 1.93e-03 | 40 | 34 | 2 | GO:0016235 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 2.22e-03 | 43 | 34 | 2 | GO:0097431 | |
| Domain | ADAM_spacer1 | 9.52e-06 | 23 | 34 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 9.52e-06 | 23 | 34 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.09e-05 | 24 | 34 | 3 | IPR013273 | |
| Domain | Peptidase_M12B_N | 4.82e-05 | 39 | 34 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 4.82e-05 | 39 | 34 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 5.20e-05 | 40 | 34 | 3 | PS00427 | |
| Domain | ADAM_MEPRO | 5.20e-05 | 40 | 34 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 5.20e-05 | 40 | 34 | 3 | PS50214 | |
| Domain | Reprolysin | 5.20e-05 | 40 | 34 | 3 | PF01421 | |
| Domain | Peptidase_M12B | 5.20e-05 | 40 | 34 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 5.60e-05 | 41 | 34 | 3 | IPR001762 | |
| Domain | zf-CXXC | 1.75e-04 | 11 | 34 | 2 | PF02008 | |
| Domain | Znf_CXXC | 1.75e-04 | 11 | 34 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 1.75e-04 | 11 | 34 | 2 | PS51058 | |
| Domain | TSP_1 | 2.03e-04 | 63 | 34 | 3 | PF00090 | |
| Domain | TSP1 | 2.23e-04 | 65 | 34 | 3 | SM00209 | |
| Domain | TSP1_rpt | 2.23e-04 | 65 | 34 | 3 | IPR000884 | |
| Domain | TSP1 | 2.23e-04 | 65 | 34 | 3 | PS50092 | |
| Domain | MetalloPept_cat_dom | 4.27e-04 | 81 | 34 | 3 | IPR024079 | |
| Domain | - | 4.27e-04 | 81 | 34 | 3 | 3.40.390.10 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 4.30e-04 | 17 | 34 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 4.30e-04 | 17 | 34 | 2 | PS51059 | |
| Domain | PARP | 4.30e-04 | 17 | 34 | 2 | PF00644 | |
| Domain | - | 4.30e-04 | 17 | 34 | 2 | 3.90.228.10 | |
| Domain | ZINC_PROTEASE | 7.45e-04 | 98 | 34 | 3 | PS00142 | |
| Domain | WGR_domain | 8.66e-04 | 24 | 34 | 2 | IPR008893 | |
| Domain | ADAM_Cys-rich | 1.10e-03 | 27 | 34 | 2 | IPR006586 | |
| Domain | ACR | 1.10e-03 | 27 | 34 | 2 | SM00608 | |
| Domain | SAM_2 | 2.77e-03 | 43 | 34 | 2 | PF07647 | |
| Domain | TPR_8 | 4.18e-03 | 53 | 34 | 2 | PF13181 | |
| Domain | Ank_2 | 6.92e-03 | 215 | 34 | 3 | PF12796 | |
| Domain | Ank | 8.13e-03 | 228 | 34 | 3 | PF00023 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.47e-05 | 39 | 27 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.47e-05 | 39 | 27 | 3 | MM15165 | |
| Pathway | WP_GABA_METABOLISM_AKA_GHB | 1.92e-04 | 11 | 27 | 2 | M42550 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.89e-04 | 68 | 27 | 3 | M27303 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 3.56e-04 | 73 | 27 | 3 | MM16641 | |
| Pathway | WP_NAD_BIOSYNTHETIC_PATHWAYS | 7.97e-04 | 22 | 27 | 2 | M39704 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.15e-03 | 109 | 27 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.21e-03 | 111 | 27 | 3 | M27416 | |
| Pathway | KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM | 1.69e-03 | 32 | 27 | 2 | M17758 | |
| Pubmed | 3.61e-07 | 1285 | 35 | 10 | 35914814 | ||
| Pubmed | Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. | 9.84e-07 | 2 | 35 | 2 | 23100278 | |
| Pubmed | Tankyrase is necessary for canonical Wnt signaling during kidney development. | 9.84e-07 | 2 | 35 | 2 | 20549720 | |
| Pubmed | Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. | 9.84e-07 | 2 | 35 | 2 | 18612384 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15795250 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12124344 | ||
| Pubmed | Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy. | 9.84e-07 | 2 | 35 | 2 | 28723574 | |
| Pubmed | Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling. | 9.84e-07 | 2 | 35 | 2 | 27494558 | |
| Pubmed | Regulation of tankyrase activity by a catalytic domain dimer interface. | 9.84e-07 | 2 | 35 | 2 | 30055800 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18026951 | ||
| Pubmed | Structural insights into SAM domain-mediated tankyrase oligomerization. | 9.84e-07 | 2 | 35 | 2 | 27328430 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19144982 | ||
| Pubmed | Rines/RNF180, a novel RING finger gene-encoded product, is a membrane-bound ubiquitin ligase. | 9.84e-07 | 2 | 35 | 2 | 18363970 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 29263426 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 23729667 | ||
| Pubmed | Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions. | 9.84e-07 | 2 | 35 | 2 | 24291818 | |
| Pubmed | Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. | 9.84e-07 | 2 | 35 | 2 | 24116873 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24323992 | ||
| Pubmed | 1.16e-06 | 1116 | 35 | 9 | 31753913 | ||
| Pubmed | Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1. | 2.95e-06 | 3 | 35 | 2 | 33361107 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 32442396 | ||
| Pubmed | Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. | 2.95e-06 | 3 | 35 | 2 | 11739745 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 26246473 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 25939383 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12646957 | ||
| Pubmed | Tankyrase inhibition aggravates kidney injury in the absence of CD2AP. | 2.95e-06 | 3 | 35 | 2 | 27441654 | |
| Pubmed | Arpin Regulates Migration Persistence by Interacting with Both Tankyrases and the Arp2/3 Complex. | 2.95e-06 | 3 | 35 | 2 | 33923443 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 34685658 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 11454873 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 21251231 | ||
| Pubmed | The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. | 2.95e-06 | 3 | 35 | 2 | 26025392 | |
| Pubmed | Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death. | 5.90e-06 | 4 | 35 | 2 | 30260955 | |
| Pubmed | PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis. | 5.90e-06 | 4 | 35 | 2 | 38272024 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 25568311 | ||
| Pubmed | Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia. | 5.90e-06 | 4 | 35 | 2 | 26791235 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 26513298 | ||
| Pubmed | Expression of prion gene and presence of prion protein during development of mouse molar tooth germ. | 5.90e-06 | 4 | 35 | 2 | 21083616 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 24394411 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 36383218 | ||
| Pubmed | Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14. | 5.90e-06 | 4 | 35 | 2 | 11278563 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23352454 | ||
| Pubmed | Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. | 5.90e-06 | 4 | 35 | 2 | 17581865 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 11854288 | ||
| Pubmed | Metalloproteinase Adamts16 Is Required for Proper Closure of the Optic Fissure. | 9.82e-06 | 5 | 35 | 2 | 29625437 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 11802774 | ||
| Pubmed | Tankyrase represses autoinflammation through the attenuation of TLR2 signaling. | 9.82e-06 | 5 | 35 | 2 | 35362478 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 22473005 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 34667079 | ||
| Pubmed | Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. | 1.47e-05 | 6 | 35 | 2 | 19759537 | |
| Pubmed | Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling. | 1.47e-05 | 6 | 35 | 2 | 21799911 | |
| Pubmed | Tankyrases Promote Homologous Recombination and Check Point Activation in Response to DSBs. | 1.47e-05 | 6 | 35 | 2 | 26845027 | |
| Pubmed | TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator. | 1.47e-05 | 6 | 35 | 2 | 25517638 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 25476119 | ||
| Pubmed | Tankyrase regulates epithelial lumen formation via suppression of Rab11 GEFs. | 1.47e-05 | 6 | 35 | 2 | 34128958 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 10988299 | ||
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 15599946 | ||
| Pubmed | Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. | 2.06e-05 | 7 | 35 | 2 | 22153076 | |
| Pubmed | Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth. | 2.06e-05 | 7 | 35 | 2 | 25547115 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 31554794 | ||
| Pubmed | RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. | 2.06e-05 | 7 | 35 | 2 | 21478859 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 23233679 | ||
| Pubmed | Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. | 3.53e-05 | 9 | 35 | 2 | 19766477 | |
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 12080061 | ||
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 24244196 | ||
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 4.40e-05 | 10 | 35 | 2 | 29276034 | |
| Pubmed | Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. | 4.40e-05 | 10 | 35 | 2 | 20659789 | |
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 5.38e-05 | 11 | 35 | 2 | 29337306 | |
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 20937264 | ||
| Pubmed | 5.91e-05 | 418 | 35 | 5 | 34709266 | ||
| Pubmed | 6.00e-05 | 75 | 35 | 3 | 20637190 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 24695699 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 35733260 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 17360405 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 1.07e-04 | 91 | 35 | 3 | 28558017 | |
| Pubmed | High-throughput RNAi screening reveals novel regulators of telomerase. | 1.17e-04 | 16 | 35 | 2 | 21531765 | |
| Pubmed | Family-wide analysis of poly(ADP-ribose) polymerase activity. | 1.17e-04 | 16 | 35 | 2 | 25043379 | |
| Pubmed | USP25 regulates Wnt signaling by controlling the stability of tankyrases. | 1.17e-04 | 16 | 35 | 2 | 28619731 | |
| Pubmed | 1.33e-04 | 17 | 35 | 2 | 26389685 | ||
| Pubmed | 1.33e-04 | 17 | 35 | 2 | 22578469 | ||
| Pubmed | 1.33e-04 | 17 | 35 | 2 | 10464288 | ||
| Pubmed | 1.41e-04 | 100 | 35 | 3 | 10048485 | ||
| Pubmed | 1.66e-04 | 19 | 35 | 2 | 22984288 | ||
| Pubmed | Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells required for self-renewal. | 1.66e-04 | 19 | 35 | 2 | 28554894 | |
| Pubmed | 1.85e-04 | 20 | 35 | 2 | 19922873 | ||
| Pubmed | A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. | 2.04e-04 | 21 | 35 | 2 | 24025145 | |
| Pubmed | 2.24e-04 | 22 | 35 | 2 | 18448648 | ||
| Pubmed | 2.24e-04 | 22 | 35 | 2 | 27521426 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.42e-04 | 120 | 35 | 3 | 31413325 | |
| Pubmed | Zic1 and Zic3 regulate medial forebrain development through expansion of neuronal progenitors. | 2.91e-04 | 25 | 35 | 2 | 17507568 | |
| Pubmed | 3.06e-04 | 130 | 35 | 3 | 12421765 | ||
| Pubmed | Onecut1 and Onecut2 play critical roles in the development of the mouse retina. | 3.40e-04 | 27 | 35 | 2 | 25313862 | |
| Pubmed | 3.93e-04 | 29 | 35 | 2 | 32123907 | ||
| Pubmed | 3.93e-04 | 29 | 35 | 2 | 29874580 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.17e-04 | 351 | 35 | 4 | 38297188 | |
| Pubmed | Forebrain Ptf1a Is Required for Sexual Differentiation of the Brain. | 4.20e-04 | 30 | 35 | 2 | 29972793 | |
| Pubmed | 4.58e-04 | 650 | 35 | 5 | 38777146 | ||
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 4.79e-04 | 32 | 35 | 2 | 31434798 | |
| Pubmed | The Trim family of genes and the retina: Expression and functional characterization. | 5.09e-04 | 33 | 35 | 2 | 30208054 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 5.22e-04 | 1451 | 35 | 7 | 30550785 | |
| Pubmed | 5.40e-04 | 376 | 35 | 4 | 24154525 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q12 | 1.17e-03 | 66 | 35 | 2 | chr5q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 4.79e-03 | 135 | 35 | 2 | chr8p21 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.72e-06 | 19 | 23 | 3 | 50 | |
| GeneFamily | Zinc fingers CXXC-type | 1.01e-04 | 12 | 23 | 2 | 136 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.08e-04 | 17 | 23 | 2 | 684 | |
| GeneFamily | Ankyrin repeat domain containing | 3.44e-03 | 242 | 23 | 3 | 403 | |
| GeneFamily | Sterile alpha motif domain containing | 5.54e-03 | 88 | 23 | 2 | 760 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 9.30e-03 | 115 | 23 | 2 | 769 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.20e-02 | 718 | 23 | 4 | 28 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.94e-05 | 209 | 34 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 3.14e-05 | 806 | 34 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 3.14e-05 | 806 | 34 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.21e-04 | 307 | 34 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.30e-04 | 312 | 34 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.82e-04 | 769 | 34 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.48e-04 | 193 | 34 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 2.66e-04 | 818 | 34 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 2.66e-04 | 818 | 34 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.45e-04 | 385 | 34 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.14e-04 | 221 | 34 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.44e-04 | 407 | 34 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_100 | 4.84e-04 | 96 | 34 | 3 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_100 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.96e-06 | 163 | 35 | 4 | db6b7ce6f7221bb73c5e650ac51cdd5d7ef00675 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.36e-06 | 165 | 35 | 4 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 192 | 35 | 4 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.55e-05 | 193 | 35 | 4 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 195 | 35 | 4 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 195 | 35 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 199 | 35 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-04 | 135 | 35 | 3 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-7|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.99e-04 | 145 | 35 | 3 | 88090a226ddfa6df59976f025bf0fd84ca0f72ef | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-04 | 158 | 35 | 3 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.61e-04 | 159 | 35 | 3 | c64fff8d89f84d1f5a0cc432e31f56f741162505 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 166 | 35 | 3 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-04 | 166 | 35 | 3 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 166 | 35 | 3 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.07e-04 | 168 | 35 | 3 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 168 | 35 | 3 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 780fb0050852626062a729dd1b82b0cf61e7e9ca | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 170 | 35 | 3 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 170 | 35 | 3 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-04 | 170 | 35 | 3 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-04 | 170 | 35 | 3 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-04 | 171 | 35 | 3 | 3ad4f138d9570500cfb4423a2be16bb7d1cacbf8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-04 | 171 | 35 | 3 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | 10x_5'_v1-Neoplastic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.45e-04 | 175 | 35 | 3 | 379f595be2273f662064c920d195a30491aa88d6 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 3.57e-04 | 177 | 35 | 3 | eb87ea93e36a8f97442ec8515f658ee61932dc0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 177 | 35 | 3 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 177 | 35 | 3 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 178 | 35 | 3 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 178 | 35 | 3 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 178 | 35 | 3 | ccd37575b60102f5e647c01546e8ff8fec638bd7 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 178 | 35 | 3 | 87b04753650e45f12299c8456fb980d6c0d5961c | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 178 | 35 | 3 | ebfae386a518ea33911ba3ff40464c94d18ef695 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-04 | 179 | 35 | 3 | 362c003503190dc272fa89185a83a65e063d7a67 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-04 | 179 | 35 | 3 | 7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-04 | 179 | 35 | 3 | e0eec8d48868c76c3e879f219357c62ceff1bc76 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-04 | 180 | 35 | 3 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-04 | 181 | 35 | 3 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-04 | 181 | 35 | 3 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-04 | 182 | 35 | 3 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-04 | 182 | 35 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-04 | 182 | 35 | 3 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.94e-04 | 183 | 35 | 3 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.94e-04 | 183 | 35 | 3 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 183 | 35 | 3 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-04 | 183 | 35 | 3 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 183 | 35 | 3 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | f06c06c75aab55fa8c803665afaa399446aec5af | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 3.94e-04 | 183 | 35 | 3 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 183 | 35 | 3 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 183 | 35 | 3 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 183 | 35 | 3 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.06e-04 | 185 | 35 | 3 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 3189e91fe26df59bd605d2b6223ceb1779daf0b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_RCN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 538db481c82b02e5d3b8e03b166f754cc936901e | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-04 | 186 | 35 | 3 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.13e-04 | 186 | 35 | 3 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-04 | 186 | 35 | 3 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-04 | 186 | 35 | 3 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.13e-04 | 186 | 35 | 3 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 186 | 35 | 3 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-04 | 186 | 35 | 3 | 3dae539cce15fcf2b1b32e981d7febe94c03c600 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-04 | 187 | 35 | 3 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-04 | 187 | 35 | 3 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.26e-04 | 188 | 35 | 3 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 188 | 35 | 3 | eadcf90b526be8fe567267da83966c8802608030 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-04 | 189 | 35 | 3 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.33e-04 | 189 | 35 | 3 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.39e-04 | 190 | 35 | 3 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.46e-04 | 191 | 35 | 3 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-04 | 191 | 35 | 3 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-04 | 191 | 35 | 3 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 192 | 35 | 3 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 192 | 35 | 3 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.53e-04 | 192 | 35 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-04 | 193 | 35 | 3 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-04 | 193 | 35 | 3 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.67e-04 | 194 | 35 | 3 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.67e-04 | 194 | 35 | 3 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-04 | 194 | 35 | 3 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-04 | 194 | 35 | 3 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster | 4.74e-04 | 195 | 35 | 3 | bc76a0586cc78f013cb96a2444e63e3c5daa3bc7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.74e-04 | 195 | 35 | 3 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| Disease | chemotherapy-induced alopecia, response to antimicrotubule agent | 7.04e-05 | 11 | 34 | 2 | EFO_0005260, EFO_0005400 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 4.12e-04 | 26 | 34 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | respiratory failure, COVID-19 | 5.13e-04 | 29 | 34 | 2 | EFO_0009686, MONDO_0100096 | |
| Disease | corneal resistance factor | 1.74e-03 | 451 | 34 | 4 | EFO_0010067 | |
| Disease | Liver carcinoma | 2.66e-03 | 507 | 34 | 4 | C2239176 | |
| Disease | chronotype measurement | 3.20e-03 | 882 | 34 | 5 | EFO_0008328 | |
| Disease | Schizophrenia | 3.21e-03 | 883 | 34 | 5 | C0036341 | |
| Disease | late-onset Alzheimers disease | 4.57e-03 | 292 | 34 | 3 | EFO_1001870 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QREEHGHMHHFALNP | 551 | Q8NHU2 | |
| FDDDIRVPFGHAHNH | 251 | Q6NXE6 | |
| HRHHFHARGEFNLMN | 291 | Q9C0A0 | |
| HANHMAAQPQFVHPE | 821 | O94985 | |
| QHEPLSFFFDIMQHH | 1026 | P78312 | |
| NKEDMHLFGHYPAHD | 81 | Q9ULK2 | |
| HELGHVFNMPHDNVK | 361 | Q8TE58 | |
| IAHEIGHNFGMNHDG | 401 | Q9UKP5 | |
| HELGHVFNMPHDDAK | 401 | Q9UHI8 | |
| NTPMDEALHFGHHDV | 621 | O94925 | |
| AAFSANERPRHHHAM | 146 | P0C860 | |
| GSRHHDFHHMNFIGN | 246 | Q15800 | |
| MPDHDQNEGFHCREE | 946 | Q8TAB3 | |
| GNHDQAMHFAEKHLE | 336 | P81274 | |
| PFQAMVQFHRHHGQE | 116 | Q9Y5P6 | |
| FHHPHQLLEGMEGFN | 141 | Q99259 | |
| IQPKDFHHHHFPDME | 496 | O75976 | |
| PEDEMQHVQHHHRFL | 401 | Q56NI9 | |
| HLNHEKEMFAQDHPE | 381 | Q16798 | |
| PDHFIQGHMDADHIS | 2991 | Q03164 | |
| HHGNGTQHMFEDDPS | 651 | Q9UBN7 | |
| PKEFHLNRGNHEDHM | 231 | O14830 | |
| HTFFIGDHANMFPHL | 701 | O15294 | |
| PHGAHRMDYLHFEDD | 541 | Q86T96 | |
| SHHLNFGMNPDHARN | 901 | Q9NRR4 | |
| GFHNPRMFEQHHPRS | 21 | A0A1B0GU33 | |
| DFCAHPHRDIHNMNN | 1666 | Q8NFU7 | |
| FEPNNHHHFGREAEM | 86 | Q8N1N0 | |
| QAMDIHFHSPAFQHP | 256 | P10909 | |
| EENHNHHNERMLFHG | 1171 | O95271 | |
| HHNERMLFHGSPFIN | 1176 | O95271 | |
| HNHANERMLFHGSPF | 1021 | Q9H2K2 | |
| HAKHEQFHNEMNFPE | 166 | Q6PF04 | |
| GEHHPEAMNVLNFDH | 906 | Q96JM2 | |
| ADGHPEMGFHHATQA | 71 | O14628 | |
| QLSNGDHHFMHDAVF | 91 | Q9BYJ9 | |
| DHHFMHDAVFGQPGG | 96 | Q9BYJ9 | |
| HHHHPGAFFRYMRQQ | 236 | O95409 |